Akoya Biosciences, Inc. (NASDAQ:AKYA) Q1 2023 Earnings Conference Call May 8, 2023 5:00 PM ET

Company Participants

Priyam Shah - Investor Relations

Brian McKelligon - Chief Executive Officer

John Ek - Chief Financial Officer

Conference Call Participants

Tim Chiang - Capital One

Mason Carrico - Stephens Inc

Ruizhi Qin - JPMorgan

Vivian Bais - BTIG

Kyle Mikson - Canaccord Genuity

David Westenberg - Piper Sandler

Lucas Baranowski - UBS

Operator

Good day and thank you for standing by. Welcome to the Akoya Biosciences First Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Please be advised that today’s conference is being recorded.

I would now like to hand it over to our first speaker.

Priyam Shah

Thank you, operator and thank you to everyone who’s joining us today on this call. I am Priyam Shah, Head of Investor Relations at Akoya Biosciences. On the call today, we have Brian McKelligon, Chief Executive Officer and John Ek, our newly appointed Chief Financial Officer. Earlier today, Akoya released financial results for the first quarter ended March 31, 2023. A copy of the press release is available on the company’s website.

Before we begin, I’d like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results, or performance are forward-looking statements.

Actual results may differ materially from those expressed or implied in the forward-looking statements due to a variety of factors. For a list and description of the risks and uncertainties associated with Akoya’s business, please refer to the risks identified in our filings with the U.S. Securities and Exchange Commission, including in the Risk Factors section of our annual report on Form 10-K for the year ended December 31, 2022, filed on March 6, 2023, and subsequent filings with the SEC, including our quarterly report on Form 10-Q for the quarter ended March 31, 2023, filed today, May 8, 2023. We urge you to consider these factors, and you should be aware that these statements are considered estimates only and are not a guarantee of future performance. This conference call contains time-sensitive information and is accurate only as of the live broadcast today, May 8, 2023.